BZBoxi Zhang

Boxi Zhang

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Boxi Zhang has a total of 75 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Discovery of Epidermal Growth Factor‐Like 7 as a Potential Non‐Invasive Biomarker for Fibrosis and Mortality Risk in MASLD

    by Heather Collis, Sara F. Hansson, Patrik Nasr, Cecilia Jönsson, Mathias Liljeblad, Björn Carlsson, Showgy Ma'AYeh, Boxi Zhang, Jana de Wiljes, Mattias Ekstedt, et al.

    Metabolic dysfunction‐associated steatotic liver disease (MASLD) is a major cause of liver‐related morbidity and mortality worldwide. Although liver biopsy remains the gold standard for assessing fibrosis and predicting outcomes, it is invasive, costly and associated with complications. Therefore, a non‐invasive assessment of fibrosis stage or outcome prediction are urgently needed. In a clinical cohort of 87 patients with biopsy‐confirmed MASLD, we developed a random forest pipeline to determine potential novel biomarkers of interest for the non‐invasive assessment of advanced fibrosis (F3–F4). We investigated the top‐ranked Boruta‐selected biomarker, epidermal growth factor‐like 7 (EGFL7), as a non‐invasive test for advanced fibrosis, using Youden's index to establish a threshold. We performed a Kaplan Meier survival analysis and Cox proportional‐hazards analysis of EGFL7 in a MASLD subpopulation of the UK Biobank to assess its predictive value for all‐cause and liver‐related mortality. This study discovered EGFL7 as a promising candidate for fibrosis classification, achieving 83% accuracy and an AUROC of 0.77. Its diagnostic performance was comparable to FIB‐4. Furthermore, our analysis of a MASLD subpopulation of the UK Biobank revealed that elevated plasma EGFL7 levels were associated with all‐cause mortality ( p < 0.0001) and liver‐related mortality ( p < 0.0001). Cox proportional‐hazards analysis revealed patients with a plasma EGFL7 level above 0.12 had a 51% (HR = 1.51, CI = [1.05–2.17], p = 0.026) higher mortality hazard than those with EGFL7 plasma value below 0.12. Our results suggest that circulating levels of plasma EGFL7 may have utility in the diagnosis and prognosis of patients with MASLD, although these finding do not yet establish EGFL7 as a clinically actionable test.

  • OlinkAnalyzeVignettes: Vignettes for Analyzing Data using 'OlinkAnalyze'

    by Kathleen Nevola, Marianne Sandin, Jamey Guess, Simon Forsberg, Christoffer Cambronero, Pascal Pucholt, Boxi Zhang, Masoumeh Sheikhi, Klev Diamanti, Amrita Kar, et al.

    Exemplifying analysis of large-scale protein data from the 'Olink platform', primarily relative protein expression data that has been exported from 'Olink NPX Software', as well as QUANT data from 'Olink'. QUANT data is log-transformed. Materials focus on reading data, demonstrating data wrangling and quality control analysis, performing statistical analysis and generating figures to visualize the results of the statistical analysis. The goal of this package is to guide users extract biological insights from large-scale protein data run on the 'Olink platform'. More information on 'Olink' data can be found at .

  • Open Access

    Oncogenic ERK signaling represses chaperone-mediated autophagy through transcriptional control of LAMP-2A

    by Eva Berenger, Merve Kacal, Alice Maestri, Elena Kochetkova, Boxi Zhang, Suresh Sajwan, Mattias Mannervik, Erik Norberg, Vitaliy O. Kaminskyy, Helin Vakifahmetoglu-Norberg

    Chaperone-mediated autophagy (CMA) is a selective lysosomal degradation pathway governed by the rate-limiting receptor LAMP-2A and increasingly implicated in cancer. However, the oncogenic circuits that enforce CMA repression and whether this state is therapeutically reversible remain unclear. Here, we developed a quantitative bioluminescence-based reporter to measure CMA activity in human cancer cells and combined parallel chemical and genome-scale CRISPR-Cas9 screens to define regulatory pathways. The chemical screen identified GSK1059615 as a CMA-restoring compound that increased LAMP-2A transcription and protein abundance in vitro and in vivo . In parallel, the CRISPR screen revealed ERK signaling as a pathway-level suppressor of CMA. Genetic or pharmacologic ERK inhibition de-repressed LAMP-2A expression, while integrated modulation of ERK, PI3K-AKT, and p38 signaling coordinated transcriptional induction and stabilization of LAMP-2A. Transcriptomic analyses further implicated FOXO1/FOXP1-driven programs in LAMP-2A regulation. Together, these findings position CMA as an integrated output of oncogenic signaling networks and establish a mechanistic framework for restoring CMA activity in defined cancer contexts.


  • Open Access

    Chaperone-mediated autophagy regulates the metastatic state of mesenchymal tumors

    by Xun Zhou, Eva Berenger, Yong Shi, Vera Shirokova, Elena Kochetkova, Tina Becirovic, Boxi Zhang, Vitaliy O Kaminskyy, Yashar Esmaeilian, Kayoko Hosaka, et al.

    Tumors often recapitulate programs to acquire invasive and dissemination abilities, during which pro-metastatic proteins are distinctively stabilized in cancer cells to drive further progression. Whether failed protein degradation affects the metastatic programs of cancer remains unknown. Here, we show that the human cancer cell-specific knockout (KO) of LAMP-2A, a limiting protein for chaperone-mediated autophagy (CMA), promotes the aggressiveness of mesenchymal tumors. Deficient CMA resulted in widespread tumor cell dissemination, invasion into the vasculature and cancer metastasis. In clinical samples, metastatic lesions showed suppressed LAMP-2A expression compared to primary tumors from the same cancer patients. Mechanistically, while stimulating TGFβ signaling dampens LAMP-2A levels, genetic suppression of CMA aggravated TGFβ signaling in cancer cells and tumors. Conversely, pharmacological inhibition of TGFβ signaling repressed the growth of LAMP-2A KO-driven tumors. Furthermore, we found that multiple EMT-driving proteins, such as TGFβR2, are degraded by CMA. Our study demonstrates that the tumor suppressive function of CMA involves negative regulation of TGFβ-driven EMT and uncovers a mechanistic link between CMA and a major feature of metastatic invasiveness.


  • OlinkAnalyze: Facilitate Analysis of Proteomic Data from Olink

    by Kathleen Nevola, Marianne Sandin, Jamey Guess, Simon Forsberg, Christoffer Cambronero, Pascal Pucholt, Boxi Zhang, Masoumeh Sheikhi, Klev Diamanti, Amrita Kar, et al.


  • Open Access

    Targetome analysis of chaperone-mediated autophagy in cancer cells

    by Yuqing Hao, Merve Kacal, Amanda Tomie Ouchida, Boxi Zhang, Erik Norberg, Helin Vakifahmetoglu-Norberg

    Chaperone-mediated autophagy (CMA) is a lysosomal degradation pathway of select soluble proteins. Nearly one-third of the soluble proteins are predicted to be recognized by this pathway, yet only a minor fraction of this proteome has been identified as CMA substrates in cancer cells. Here, we undertook a quantitative multiplex mass spectrometry approach to study the proteome of isolated lysosomes in cancer cells during CMA-activated conditions. By integrating bioinformatics analyses, we identified and categorized proteins of multiple cellular pathways that were specifically targeted by CMA. Beyond verifying metabolic pathways, we show that multiple components involved in select biological processes, including cellular translation, was specifically targeted for degradation by CMA. In particular, several proteins of the translation initiation complex were identified as bona fide CMA substrates in multiple cancer cell lines of distinct origin and we show that CMA suppresses cellular translation. We further show that the identified CMA substrates display high expression in multiple primary cancers compared to their normal counterparts. Combined, these findings uncover cellular processes affected by CMA and reveal a new role for CMA in the control of translation in cancer cells. Abbreviations: 6-AN: 6-aminonicotinamide; ACTB: actin beta; AR7: atypical retinoid 7; CHX: cycloheximide; CMA: chaperone-mediated autophagy; CQ: chloroquine; CTS: cathepsins; DDX3X: DEAD-box helicase 3 X-linked; EEF2: eukaryotic translation elongation factor 2; EIF4A1: eukaryotic translation initiation factor 4A1; EIF4H: eukaryotic translation initiation factor 4H; GEO: Gene Expression Omnibus; GO: Gene Ontology; GSEA: gene set enrichment analysis; HK2: hexokinase 2; HSPA8/HSC70: heat shock protein family A (Hsp70) member 8; LAMP: lysosomal-associated membrane protein; LDHA: lactate dehydrogenase A; NES: normalized enrichment score; NFKBIA: NFKB inhibitor alpha; PCA: principle component analysis; PQ: paraquat; S.D.: standard deviation; SUnSET: surface sensing of translation; TMT: tandem mass tags; TOMM40/TOM40: translocase of outer mitochondrial membrane 40.


  • Open Access

    Human renal fibroblasts are strong immunomobilizers during a urinary tract infection mediated by uropathogenic Escherichia coli

    by Kristin Klarström Engström, Boxi Zhang, Isak Demirel

    To prevent the onset of urosepsis and reduce mortality, a better understanding of how uropathogenicEscherichia coli(UPEC) manages to infiltrate the bloodstream through the kidneys is needed. The present study elucidates if human renal interstitial fibroblasts are part of the immune response limiting a UPEC infection, or if UPEC has the ability to modulate the fibroblasts for their own gain. Microarray results showed that upregulated genes were associated with an activated immune response. We also found that chemokines released from renal fibroblasts upon a UPEC infection could be mediated by LPS and triacylated lipoproteins activating the TLR2/1, TLR4, MAPK, NF-κB and PKC signaling pathways. Furthermore, UPEC was also shown to be able to adhere and invade renal fibroblasts, mediated by the P-fimbriae. Furthermore, it was found that renal fibroblasts were more immunoreactive than renal epithelial cells upon a UPEC infection. However, both renal fibroblasts and epithelial cells were equally efficient at inducing neutrophil migration. In conclusion, we have found that human renal fibroblasts can sense UPEC and mobilize a host response with neutrophil migration. This suggests that renal fibroblasts are not only structural cells that produce and regulate the extracellular matrix, but also highly immunoreactive cells.


  • USP10 regulates the stability of the EMT-transcription factor Slug/SNAI2

    by Amanda Tomie Ouchida, Merve Kacal, Adi Zheng, Gorbatchev Ambroise, Boxi Zhang, Erik Norberg, Helin Vakifahmetoglu-Norberg


  • miR-126-5p targets Malate Dehydrogenase 1 in non-small cell lung carcinomas

    by Andre Lima Queiroz, Boxi Zhang, Dawn E. Comstock, Yuqing Hao, Matilda Eriksson, Per Hydbring, Helin Vakifahmetoglu-Norberg, Erik Norberg


  • Open Access

    Dual action of bacteriocin PLNC8 αβ through inhibition of Porphyromonas gingivalis infection and promotion of cell proliferation

    by Torbjörn Bengtsson, Boxi Zhang, Robert Selegård, Emanuel Wiman, Daniel Aili, Hazem Khalaf

    Periodontitis is a chronic inflammatory disease that is characterised by accumulation of pathogenic bacteria, including Porphyromonas gingivalis, in periodontal pockets. The lack of effective treatments has emphasised in an intense search for alternative methods to prevent bacterial colonisation and disease progression. Bacteriocins are bacterially produced antimicrobial peptides gaining increased consideration as alternatives to traditional antibiotics. We show rapid permeabilisation and aggregation of P. gingivalis by the two-peptide bacteriocin PLNC8 αβ. In a cell culture model, P. gingivalis was cytotoxic against gingival fibroblasts. The proteome profile of fibroblasts is severely affected by P. gingivalis, including induction of the ubiquitin-proteasome pathway. PLNC8 αβ enhanced the expression of growth factors and promoted cell proliferation, and suppressed proteins associated with apoptosis. PLNC8 αβ efficiently counteracted P. gingivalis-mediated cytotoxicity, increased expression of a large number of proteins and restored the levels of inflammatory mediators. In conclusion, we show that bacteriocin PLNC8 αβ displays dual effects by acting as a potent antimicrobial agent killing P. gingivalis and as a stimulatory factor promoting cell proliferation. We suggest preventive and therapeutical applications of PLNC8 αβ in periodontitis to supplement the host immune defence against P. gingivalis infection and support wound healing processes.